| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,899 |
9,995 |
$786K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,329 |
5,571 |
$556K |
| 80053 |
Comprehensive metabolic panel |
5,613 |
4,699 |
$38K |
| 80061 |
Lipid panel |
3,544 |
2,961 |
$30K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,685 |
4,696 |
$25K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
167 |
156 |
$24K |
| 93000 |
|
1,625 |
1,336 |
$22K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,720 |
2,219 |
$18K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,039 |
692 |
$15K |
| 71046 |
Radiologic examination, chest; 2 views |
583 |
484 |
$13K |
| 84439 |
|
1,804 |
1,430 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
7,474 |
6,074 |
$12K |
| 87428 |
|
217 |
193 |
$12K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
81 |
62 |
$12K |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
626 |
531 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
962 |
780 |
$9K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
91 |
79 |
$8K |
| 99454 |
|
641 |
528 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
671 |
551 |
$7K |
| 81003 |
|
3,318 |
2,714 |
$7K |
| 96127 |
|
1,612 |
1,306 |
$6K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
49 |
39 |
$6K |
| 99457 |
|
706 |
579 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
166 |
107 |
$5K |
| 86769 |
|
137 |
132 |
$5K |
| 3074F |
|
4,602 |
3,671 |
$5K |
| G8539 |
Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment |
1,809 |
1,462 |
$4K |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
614 |
502 |
$4K |
| 3008F |
|
4,944 |
3,796 |
$4K |
| 96160 |
|
1,535 |
1,244 |
$4K |
| 90688 |
|
179 |
159 |
$3K |
| 3044F |
|
1,877 |
1,541 |
$3K |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
476 |
403 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
55 |
40 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
155 |
139 |
$2K |
| 3078F |
|
3,814 |
3,052 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
18 |
13 |
$2K |
| 3075F |
|
1,751 |
1,441 |
$2K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
108 |
88 |
$2K |
| 99458 |
|
123 |
66 |
$2K |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
205 |
181 |
$1K |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
98 |
84 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
59 |
52 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
32 |
25 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
13 |
12 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
126 |
93 |
$1K |
| 80050 |
General health panel |
767 |
600 |
$956.36 |
| 3077F |
|
1,614 |
1,304 |
$732.00 |
| 0011A |
|
19 |
18 |
$720.00 |
| G8482 |
Influenza immunization administered or previously received |
97 |
79 |
$699.46 |
| 99051 |
|
67 |
39 |
$675.00 |
| 0012A |
|
16 |
15 |
$600.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
76 |
32 |
$504.18 |
| 81025 |
|
28 |
26 |
$175.08 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
860 |
682 |
$170.65 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
97 |
83 |
$103.65 |
| 3015F |
|
31 |
27 |
$60.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
26 |
25 |
$40.46 |
| 3051F |
|
15 |
12 |
$40.04 |
| 3079F |
|
2,903 |
2,346 |
$12.71 |
| 3080F |
|
1,241 |
1,028 |
$5.94 |
| 91301 |
|
94 |
82 |
$0.44 |
| 3048F |
|
1,078 |
896 |
$0.33 |
| 3050F |
|
225 |
197 |
$0.08 |
| 3049F |
|
291 |
254 |
$0.01 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
236 |
176 |
$0.01 |
| 4274F |
|
64 |
60 |
$0.01 |
| 1220F |
|
137 |
122 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
30 |
25 |
$0.00 |
| 3017F |
|
226 |
178 |
$0.00 |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
14 |
12 |
$0.00 |
| 3014F |
|
14 |
14 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
75 |
71 |
$0.00 |
| 90662 |
|
20 |
13 |
$0.00 |